Senior insider sale
HALOZYME THERAPEUTICS, INC. — senior position signals high conviction
$547.5K
7.30K shares
What this filing means
KRISHNAN MAHESH plans to sell 7.30K shares of HALOZYME THERAPEUTICS, INC. valued at approximately $547.5K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/29/2026ACC: 0001950047-26-006595
Director
Since Apr 2024
7.30K
Shares to sell
$547.5K
Approx. market value
7.30K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Exercise of Stock Options
Cash
6/29/2026
7.30KTotal acquired7.30K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/29/2026 | Exercise of Stock Options Cash | 7.30K | — |
| Total | 7.30K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
7.30K
Market value
$547.5K
6/29/2026
Total
Units
7.30K
Value
$547.5K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
6/29/2026 | 7.30K | $547.5K | NASDAQ | Planned |
| Total | 7.30K | $547.5K | ||